当前位置:首页 - 行情中心 - 广康生化(300804) - 财务分析 - 现金流量表

广康生化

(300804)

  

流通市值:12.50亿  总市值:33.63亿
流通股本:2750.00万   总股本:7400.00万

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金189,826,237.2891,069,802.74557,486,219.82409,296,882.92
  收到的税费返还45,667,996.229,787,532.3828,744,613.1221,225,086.69
  收到其他与经营活动有关的现金5,325,298.091,575,835.375,016,552.582,567,108.51
  经营活动现金流入小计240,819,531.59102,433,170.49591,247,385.52433,089,078.12
  购买商品、接受劳务支付的现金224,470,022.62111,785,590.69340,343,688.08263,239,333.7
  支付给职工以及为职工支付的现金54,313,702.9930,916,634.45104,058,954.4980,333,476.72
  支付的各项税费722,197.03374,606.298,788,933.86,947,864.97
  支付其他与经营活动有关的现金34,763,627.4117,342,200.6457,136,480.6441,283,247.55
  经营活动现金流出小计314,269,550.05160,419,032.07510,328,057.01391,803,922.94
  经营活动产生的现金流量净额-73,450,018.46-57,985,861.5880,919,328.5141,285,155.18
二、投资活动产生的现金流量:
  收回投资收到的现金369,000,000150,000,0002,202,000,0002,172,000,000
  取得投资收益收到的现金2,537,091.19511,717.775,858,700.645,787,239.23
  投资活动现金流入小计371,537,091.19150,511,717.772,207,858,700.642,177,787,239.23
  购建固定资产、无形资产和其他长期资产支付的现金173,653,125.13126,194,415.07231,548,308.38159,434,628.34
  投资支付的现金69,000,00039,000,0002,122,000,0001,872,000,000
  投资活动现金流出小计242,653,125.13165,194,415.072,353,548,308.382,031,434,628.34
  投资活动产生的现金流量净额128,883,966.06-14,682,697.3-145,689,607.74146,352,610.89
三、筹资活动产生的现金流量:
  吸收投资收到的现金450,000---
  其中:子公司吸收少数股东投资收到的现金450,000---
  取得借款收到的现金151,620,876.08110,496,876.08338,068,640.28297,438,945.18
  收到其他与筹资活动有关的现金37,457,239.6313,983,535.4243,107,081.4629,862,433.59
  筹资活动现金流入小计189,528,115.71124,480,411.5381,175,721.74327,301,378.77
  偿还债务支付的现金100,674,603.4294,519,882.21199,054,403.18137,713,921.5
  分配股利、利润或偿付利息支付的现金17,003,998.642,848,987.9510,978,161.847,998,290.4
  支付其他与筹资活动有关的现金16,627,778.623,886,920.2855,941,142.3341,713,710.91
  筹资活动现金流出小计134,306,380.68101,255,790.44265,973,707.35187,425,922.81
  筹资活动产生的现金流量净额55,221,735.0323,224,621.06115,202,014.39139,875,455.96
四、汇率变动对现金及现金等价物的影响-1,606,646.75-916,708.91,312,615.261,389,431.87
五、现金及现金等价物净增加额109,049,035.88-50,360,646.7251,744,350.42328,902,653.9
  加:期初现金及现金等价物余额173,460,018.23173,460,018.23121,715,667.81122,488,135.19
  期末现金及现金等价物余额282,509,054.11123,099,371.51173,460,018.23451,390,789.09
补充资料:
  净利润4,209,974.5-40,417,901.23-
  资产减值准备2,764,755.85-2,283,946.97-
  固定资产和投资性房地产折旧39,954,494.17-65,735,771.25-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧39,954,494.17-65,735,771.25-
  无形资产摊销1,279,105.27-3,780,115.34-
  长期待摊费用摊销2,049,577.04-2,310,958.92-
  处置固定资产、无形资产和其他长期资产的损失--15,128.49-
  固定资产报废损失1,402,985.28-3,212,438.76-
  公允价值变动损失-81,351--289,556.61-
  财务费用11,080,699.87-10,533,618.9-
  投资损失-1,656,990.04--6,368,040.75-
  递延所得税-2,294,435.78--1,040,455.76-
  其中:递延所得税资产减少-1,950,025.99--458,293.81-
    递延所得税负债增加-344,409.79--582,161.95-
  存货的减少-38,230,694.5--71,834,618.15-
  经营性应收项目的减少-42,116,496.07--125,850,871.74-
  经营性应付项目的增加-52,492,364.86-156,970,361.99-
  其他365,675.2---
  现金的期末余额282,509,054.11-173,460,018.23-
  减:现金的期初余额173,460,018.23-121,715,667.81-
  现金及现金等价物的净增加额109,049,035.88-51,744,350.42-
公告日期2026-08-282026-04-242026-04-242025-10-24
审计意见(境内)标准无保留意见
TOP↑